News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
278,782 Results
Type
Article (16730)
Company Profile (29)
Press Release (262023)
Multimedia
Podcasts (21)
Webinars (7)
Section
Business (87048)
Career Advice (700)
Deals (19307)
Drug Delivery (45)
Drug Development (36072)
Employer Resources (82)
FDA (5753)
Job Trends (5866)
News (146945)
Policy (10592)
Tag
Academia (1210)
Academic (1)
Accelerated approval (2)
Adcomms (6)
Allergies (44)
Alliances (18805)
ALS (47)
Alzheimer's disease (563)
Antibody-drug conjugate (ADC) (46)
Approvals (5760)
Artificial intelligence (112)
Autoimmune disease (14)
Automation (4)
Bankruptcy (173)
Best Places to Work (4666)
BIOSECURE Act (8)
Biosimilars (45)
Biotechnology (21)
Bladder cancer (33)
Brain cancer (15)
Breast cancer (112)
Cancer (946)
Cardiovascular disease (98)
Career advice (592)
Career pathing (13)
CAR-T (74)
Cell therapy (187)
Cervical cancer (13)
Clinical research (30564)
Collaboration (293)
Company closure (1)
Compensation (55)
Complete response letters (3)
COVID-19 (1261)
CRISPR (14)
C-suite (124)
Cystic fibrosis (43)
Data (1142)
Denatured (14)
Depression (17)
Diabetes (150)
Diagnostics (2719)
Digital health (7)
Diversity (5)
Diversity, equity & inclusion (30)
Drug discovery (53)
Drug pricing (53)
Drug shortages (20)
Duchenne muscular dystrophy (47)
Earnings (37647)
Editorial (33)
Employer branding (10)
Employer resources (75)
Events (33957)
Executive appointments (394)
FDA (6344)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (568)
Gene editing (43)
Generative AI (10)
Gene therapy (159)
GLP-1 (383)
Government (1392)
Grass and pollen (2)
Guidances (113)
Healthcare (7993)
Huntington's disease (10)
IgA nephropathy (16)
Immunology and inflammation (70)
Indications (7)
Infectious disease (1333)
Inflammatory bowel disease (76)
Inflation Reduction Act (6)
Influenza (24)
Intellectual property (46)
Interviews (114)
IPO (9856)
IRA (25)
Job creations (1348)
Job search strategy (522)
Kidney cancer (5)
Labor market (15)
Layoffs (164)
Leadership (10)
Legal (2100)
Liver cancer (32)
Lung cancer (110)
Lymphoma (66)
Machine learning (4)
Management (26)
Manufacturing (150)
MASH (52)
Medical device (5719)
Medtech (5721)
Mergers & acquisitions (9901)
Metabolic disorders (382)
Multiple sclerosis (45)
NASH (15)
Neurodegenerative disease (42)
Neuropsychiatric disorders (11)
Neuroscience (822)
NextGen: Class of 2025 (2968)
Non-profit (1841)
Now hiring (1)
Obesity (193)
Opinion (88)
Ovarian cancer (25)
Pain (48)
Pancreatic cancer (44)
Parkinson's disease (64)
Partnered (9)
Patents (87)
Patient recruitment (64)
Peanut (22)
People (26248)
Pharmaceutical (15)
Pharmacy benefit managers (11)
Phase I (7741)
Phase II (13493)
Phase III (11491)
Pipeline (942)
Policy (80)
Postmarket research (1224)
Preclinical (2988)
Press Release (36)
Prostate cancer (52)
Psychedelics (12)
Radiopharmaceuticals (111)
Rare diseases (181)
Real estate (2162)
Recruiting (28)
Regulatory (7983)
Reports (17)
Research institute (1049)
Resumes & cover letters (95)
Rett syndrome (1)
RNA editing (1)
RSV (23)
Schizophrenia (40)
Series A (115)
Series B (74)
Service/supplier (3)
Sickle cell disease (24)
Special edition (3)
Spinal muscular atrophy (64)
Sponsored (7)
Startups (2536)
State (1)
Stomach cancer (4)
Supply chain (28)
Tariffs (23)
The Weekly (7)
Vaccines (348)
Venture capitalists (41)
Weight loss (128)
Women's health (22)
Worklife (8)
Date
Last 7 days (494)
Last 30 days (1345)
Last 365 days (15129)
2025 (5526)
2024 (16282)
2023 (18181)
2022 (21806)
2021 (24336)
2020 (23001)
2019 (20013)
2018 (15087)
2017 (14617)
2016 (13018)
2015 (16056)
2014 (11308)
2013 (8511)
2012 (9394)
2011 (10000)
2010 (8921)
Location
Africa (327)
Alabama (16)
Alaska (4)
Arizona (73)
Arkansas (3)
Asia (18196)
Australia (3274)
California (2735)
Canada (1064)
China (213)
Colorado (132)
Connecticut (151)
Delaware (63)
Europe (43681)
Florida (423)
Georgia (109)
Idaho (19)
Illinois (224)
India (16)
Indiana (135)
Iowa (4)
Japan (88)
Kansas (52)
Kentucky (9)
Louisiana (8)
Maine (23)
Maryland (402)
Massachusetts (1809)
Michigan (148)
Minnesota (182)
Mississippi (1)
Missouri (32)
Montana (9)
Nebraska (9)
Nevada (39)
New Hampshire (27)
New Jersey (839)
New Mexico (11)
New York (940)
North Carolina (409)
North Dakota (1)
Northern California (1141)
Ohio (69)
Oklahoma (6)
Oregon (8)
Pennsylvania (649)
Puerto Rico (4)
Rhode Island (11)
South America (497)
South Carolina (9)
Southern California (1124)
Tennessee (30)
Texas (445)
United States (10425)
Utah (67)
Virginia (84)
Washington D.C. (16)
Washington State (308)
West Virginia (2)
Wisconsin (18)
278,782 Results for "mdb capital group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hengdian Group Capital and Apeloa Pharmaceutical to participate in 2025 J.P. Morgan Healthcare Conference
January 10, 2025
·
2 min read
Press Releases
neurocare group AG Receives EUR 19.3 Million Investment From Impact Expansion and TVM Capital Healthcare
February 5, 2025
·
3 min read
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
Press Releases
Orion Group Interim Report January–March 2025
April 23, 2025
·
6 min read
Press Releases
LSL PHARMA GROUP REPORTS ITS FOURTH QUARTER AND YEAR-END 2024 RESULTS
May 2, 2025
·
11 min read
Press Releases
Pharming Group reports first quarter 2025 financial results and provides business update
May 8, 2025
·
25 min read
Mergers & acquisitions
Acelyrin Adopts Poison Pill to Ward Off Tang Capital Buy
The move by Acelyrin’s board comes as the venture capital firm has taken larger and larger stakes in the company in an attempt to disrupt a merger with Alumis.
March 13, 2025
·
1 min read
·
Dan Samorodnitsky
Business
MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference
September 5, 2024
·
1 min read
Press Releases
Ace Vision Group Announces Initial Close of $29.4 Million Series B Financing Round
April 24, 2025
·
2 min read
Press Releases
World Ovarian Cancer Coalition Launches Global Expert Advisory Group on Ovarian Cancer
May 8, 2025
·
4 min read
1 of 27,879
Next
